Vaccines, human use in China 2021 Exports | Imports : $15.4B | $1.48B, World Rnk 2 / 135 Rnk 22 / 4600 | World Rnk 21 / 219 Rnk 171 / 4550
2020 - 2021 FASTEST GROWING MARKET | FASTEST GROWING ORIGIN: $1.9B | $307M, Indonesia | Ireland
2021 ECONOMIC COMPLEXITY of China: 1.07, Rnk 25 / 131
Exports In 2021, China exported $15.4B in Vaccines, human use, making it the 2nd largest exporter of Vaccines, human use in the world. At the same year, Vaccines, human use was the 22nd most exported product in China. The main destination of Vaccines, human use exports from China are: Indonesia ($1.94B), Pakistan ($1.46B), United Arab Emirates ($1.1B), Brazil ($1.09B), and Bangladesh ($940M).
The fastest growing export markets for Vaccines, human use of China between 2020 and 2021 were Indonesia ($1.9B), Pakistan ($1.46B), and Brazil ($1.03B).
Imports In 2021, China imported $1.48B in Vaccines, human use, becoming the 21st largest importer of Vaccines, human use in the world. At the same year, Vaccines, human use was the 171st most imported product in China. China imports Vaccines, human use primarily from: Ireland ($585M), France ($370M), Belgium ($354M), United States ($84M), and United Kingdom ($38.1M).
The fastest growing import markets in Vaccines, human use for China between 2020 and 2021 were Ireland ($307M), France ($48.5M), and United Kingdom ($37.3M).
Tariffs In 2018, the average tariff for China in Vaccines, human use was 2.34%. The countries with the highest import tariffs for Vaccines, human use were Burkina Faso (Most Favoured Nation duty rate treatment, 3%), Botswana (Most Favoured Nation duty rate treatment, 3%), Cote d'Ivoire (Most Favoured Nation duty rate treatment, 3%), Cameroon (Most Favoured Nation duty rate treatment, 3%), and Democratic Republic of the Congo (Most Favoured Nation duty rate treatment, 3%).
December 2021
Overview In December 2021 China's Vaccines, human use exports accounted up to $1.2B and imports accounted up to $246M, resulting in a positive trade balance of $950M. Between December 2020 and December 2021 the exports of China's Vaccines, human use have increased by $1.01B (526%) from $191M to $1.2B, while imports increased by $29.6M (13.7%) from $216M to $246M.
Destinations In December 2021, Vaccines, human use were exported mostly to , and were imported mostly from .
Growth In December 2021, the increase in Vaccines, human use's year-by-year exports was explained primarily by an increase in exports to . In December 2021, the increase in Vaccines, human use's year-by-year imports was explained primarily by an increase in imports from .
EXPORT GROWTH (December 2020 - December 2021): $1.01B, (526%)
IMPORT GROWTH (December 2020 - December 2021): $29.6M, (13.7%)
MAIN EXPORTER (December 2021): ,
MAIN DESTINATION (December 2021): ,
This section shows Vaccines, human use's exports and imports data at subnational level for China. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, human use over time.
For full datasets download visit Bulk Download page.
The following visualization shows the unit prices for Vaccines, human use throughout time. Products without a clear unit are excluded.
Using January 2020 exchange rates when trade data is reported in local currency.
EXPORTS (2021): $15.4B
IMPORTS (2021): $1.48B
NET TRADE (2021): $13.9B
In 2021, China exported $15.4B in Vaccines, human use. The main destinations of China exports on Vaccines, human use were Indonesia ($1.94B), Pakistan ($1.46B), United Arab Emirates ($1.1B), Brazil ($1.09B), and Bangladesh ($940M).
In 2021, China imported $1.48B in Vaccines, human use, mainly from Ireland ($585M), France ($370M), Belgium ($354M), United States ($84M), and United Kingdom ($38.1M).
THE FASTEST GROWING Vaccines, human use EXPORT MARKETS FOR China WERE (2020 - 2021):
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, human use BY China WERE (2020 - 2021):
In 2021, China's main exporting competitors in Vaccines, human use were:
In 2021, China's main importing competitors in Vaccines, human use were:
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v5.1.15 owl